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ABSTRACT
Background: A very limited amount of research has examined
intermittent fasting (IF) programs, such as time-restricted feeding
(TRF), in active populations.
Objective: Our objective was to examine the effects of TRF, with
or without β-hydroxy β-methylbutyrate (HMB) supplementation,
during resistance training (RT).
Methods: This study employed a randomized, placebo-controlled,
reduced factorial design and was double-blind with respect to
supplementation in TRF groups. Resistance-trained females were
randomly assigned to a control diet (CD), TRF, or TRF plus 3
g/d HMB (TRFHMB). TRF groups consumed all calories between
1200 h and 2000 h, whereas the CD group ate regularly from
breakfast until the end of the day. All groups completed 8 wk of
supervised RT and consumed supplemental whey protein. Body
composition, muscular performance, dietary intake, physical activity,
and physiological variables were assessed. Data were analyzed prior
to unblinding using mixed models and both intention-to-treat (ITT)
and per protocol (PP) frameworks.
Results: Forty participants were included in ITT, and 24 were
included in PP. Energy and protein intake (1.6 g/kg/d) did not
differ between groups despite different feeding durations (TRF and
TRFHMB: ∼7.5 h/d; CD: ∼13 h/d). Comparable fat-free mass (FFM)
accretion (+2% to 3% relative to baseline) and skeletal muscle
hypertrophy occurred in all groups. Differential effects on fat mass
(CD: +2%; TRF: −2% to −4%; TRFHMB: −4% to −7%) were
statistically significant in the PP analysis, but not ITT. Muscular
performance improved without differences between groups. No
changes in physiological variables occurred in any group, and
minimal side effects were reported.
Conclusions: IF, in the form of TRF, did not attenuate RT adaptations
in resistance-trained females. Similar FFM accretion, skeletal muscle
hypertrophy, and muscular performance improvements can be
achieved with dramatically different feeding programs that contain
similar energy and protein content during RT. Supplemental HMB
during fasting periods of TRF did not definitively improve outcomes.
This study was prospectively registered at clinicaltrials.gov as
NCT03404271. Am J Clin Nutr 2019;00:1–13.
Keywords: intermittent fasting, intermittent energy restriction,
energy restriction, fat loss, muscle mass, resistance exercise, weight
training, body composition, muscular strength, protein
Introduction
Intermittent fasting (IF) is a broad term encompassing eating
patterns with regularly occurring periods of food abstention
longer than a typical overnight fast (1). In contrast to traditional
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methods of continuous energy restriction, IF programs utilize
intermittent energy restriction by interspersing periods of less
restricted or unrestricted feeding with periods of severely
limited energy intake. Several forms of IF have been described,
including time-restricted feeding (TRF), alternate-day fasting
(ADF), alternate-day modified fasting, and periodic fasting (2).
The vast majority of existing research in humans has focused on
weight loss and health effects induced by IF in overweight and
obese adults. Cumulatively, this research has demonstrated that
IF programs are viable, albeit not inherently superior, alternatives
to traditional continuous energy restriction for weight loss and
health improvement (3–5).
Although an increasing body of research has reported the
physiological effects of IF, a very limited number of controlled
trials have taken place in active or exercising individuals
(6–8). Two previous investigations reported the effects of TRF in
adult males performing resistance training (RT) (7, 8). Although
Tinsley et al. (7) observed an apparent attenuation in lean soft
tissue (LST) accretion during 8 wk of TRF, this result was
confounded by the TRF group self-selecting a protein intake
lower than the control diet (CD) (1.0 compared with 1.4 g/kg/d)
and suboptimal for active individuals (9, 10). Nonetheless, com-
parable improvements in muscular performance were observed
in both groups. Moro et al. (8) prescribed higher protein intake
(1.9 g/kg/d) in TRF and CD and found that, although both
groups maintained fat-free mass (FFM) and demonstrated similar
muscular performance, TRF produced significant reductions
in fat mass (FM) and differential effects on physiological
markers.
The prevalence of IF eating patterns in active individuals and
the paucity of existing research in this population indicate the
need for further research. Additionally, as the aforementioned
investigations were conducted in male participants only, and
potential sex differences in responses to IF have been reported
(11, 12), an examination of IF plus RT in females is warranted.
Furthermore, since IF programs necessitate prolonged periods
without amino acid-induced stimulation of muscle protein
synthesis and suppression of muscle protein breakdown (13),
it has been questioned whether modification of fasting periods
to allow ingestion of amino acids or their metabolites may
be beneficial for lean mass maintenance or accretion during
IF (14). Due to its ability to influence muscle protein balance
(15), the leucine metabolite β-hydroxy β-methylbutyrate (HMB)
has been hypothesized to exert favorable effects on skeletal
muscle in exercising and/or energy-restricted individuals (16–
18). However, this has not been sufficiently examined in the
context of IF. Therefore, the purpose of this study was to
compare the physiological and performance effects of TRF,
with or without HMB supplementation during fasting periods,
to a CD requiring breakfast consumption during progressive
RT in resistance-trained females. Primary outcomes of interest
were FM reduction, FFM accretion, and skeletal muscle hy-
pertrophy in response to RT. Secondary outcomes of interest
included muscular performance (e.g. strength and endurance),
as well as commonly evaluated physiological variables such
as resting metabolic rate, substrate utilization, vascular func-
tion, and concentrations of glucose, insulin, blood lipids, and
cortisol.
Methods
Overview
This study employed a randomized, placebo-controlled,
reduced factorial design. The experiment was double-blind
with respect to HMB and placebo supplements and single-
blind when possible with respect to the assigned dietary
program. The study was prospectively registered at clinical
trials.gov as NCT03404271 and was approved by the Texas
Tech University Institutional Review Board (IRB2017-912). The
following primary outcome measures were specified a priori:
FM, FFM, body fat percentage (BF%), muscle thickness of
the elbow flexor muscles (MTEF), and muscle thickness of the
knee extensor muscles (MTKE). Secondary outcome measures
specified a priori included metrics of muscular performance,
resting metabolic rate, blood markers, blood pressure, arterial
stiffness, physical activity level, and questionnaire responses.
Data collection occurred from January to August 2018 at Texas
Tech University in Lubbock, Texas, USA. The procedures
followed were in accordance with the ethical standards of the
Texas Tech University Institutional Review Board.
Participants
Healthy female participants aged between 18 and 30 y were
recruited via posters, e-mail announcements, and word of mouth.
Participants were required to have prior RT experience, defined
as reporting ≥1 y of RT at a frequency of 2 to 4 sessions
per week and with weekly training of major upper- and lower-
body muscle groups. Additionally, participants were screened
for BF% using multifrequency bioelectrical impedance analysis
(MFBIA; mBCA 514/515, Seca). The original target BF% range
for participants was 15 to 29%; however, due to data from our lab
indicating overestimations of body fat viaMFBIA compared with
a 4-component (4C) model in resistance-trained females (19),
individuals with ≤33% body fat at screening were considered
eligible. Individuals were excluded if they did not meet the
aforementioned criteria or were pregnant, trying to become
pregnant, currently breastfeeding, cigarette smokers, allergic to
dairy protein, or had a pacemaker or other electrical implant.
Eligible participants were stratified based on BF% at screening
(15–21% or >21%) and habitual breakfast consumption (≥5
d/wk compared with <5 d/wk), and then randomly assigned
to 1 of the 3 study groups [CD plus placebo (CD), TRF plus
placebo (TRF), or TRF plus HMB (TRFHMB)] using sequences
produced from a random sequence generator (http://www.rand
om.org) and based on a 1:1:1 allocation ratio. Each participant
within a given stratum was allocated in a sequential manner
to the first available group assignment at the time of baseline
[i.e., week 0 (W0)] testing using the random integer sequence
for that stratum. The generation of random sequences and
implementation of stratified randomization were performed by
the primary investigator (GMT).
Nutrition and supplementation program
TRF and TRFHMB participants were instructed to consume
all calories between 1200 h and 2000 h each day, and CD
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TABLE 1 Resistance training program1
Upper body A2 Lower body A
Exercise W0–W4 W4–W8 Exercise W0–W4 W4–W8
Bentover DB rows 4 × 8–12, 120 s 5 × 6–8, 180 s BB deadlift 4 × 8–12, 120 s 5 × 6–8, 180 s
DB bench press 4 × 8–12, 120 s Hip sled 4 × 8–12, 120 s 5 × 6–8, 180 s
BB shoulder press 4 × 8–12, 120 s Lunges with DB 4 × 8–12, 120 s
DB flyes 4 × 8–12, 90 s Leg curls 4 × 8–12, 90 s
Preacher curls 4 × 8–12, 90 s Leg extensions 4 × 8–12, 90 s
Triceps extension 4 × 8–12, 90 s
Upper body B Lower body B
Exercise W0–W4 W4–W8 Exercise W0–W4 W4–W8
BB bench press 4 × 8–12, 120 s 5 × 6–8, 180 s BB back squat 4 × 8–12, 120 s 5 × 6–8, 180 s
Bentover DB rows 4 × 8–12, 120 s Stiff-leg deadlift 4 × 8–12, 120 s 5 × 6–8, 180 s
DB shoulder press 4 × 8–12, 120 s Lunges with DB 4 × 8–12, 120 s
DB curls 4 × 8–12, 90 s Leg curls 4 × 8–12, 90 s
Skullcrushers 4 × 8–12, 90 s Leg extensions 4 × 8–12, 90 s
Inverted rows (BW) 4 × 8–12, 90 s
1Exercise prescription shown as: sets × repetition range, rest interval. BB, barbell; BW, bodyweight; DB, dumbbell; W0, week 0; W4, week 4; W8,
week 8.
2Participants completed sessions in the following order: upper body A, lower body A, upper body B, lower body B. These 4 sessions were alternated in
this order throughout the intervention, with adjustment of load as often as necessary to ensure momentary muscular exhaustion in the specified repetition
range.
participants were instructed to consume breakfast as soon as
possible after waking and to continue to eat at self-selected
intervals throughout the remainder of the day. In addition
to the assigned eating schedule, participants were provided
with a minimal amount of dietary advice based on protein
intake goals, the results of their weighed diet records, and the
results of W0 metabolism testing. Specifically, participants were
instructed to consume the provided whey protein supplement
(Elite 100%Whey, Dymatize Enterprises, LLC) on both training
and nontraining days in order to achieve a protein intake
≥1.4 g/kg/d. Supplemental whey protein was selected as a
feasible method for increasing dietary protein intake to align
with recommendations for lean mass accretion or retention in
exercising individuals (9). The energy content of supplemental
protein was ∼200–250 kcal/d. In all groups, target energy intake
was prescribed by multiplying resting energy expenditure (REE),
assessed via indirect calorimetry, by an activity factor of 1.5 and
then subtracting 250 kcal. The goal of the small caloric reduction
was to promote fat loss while still providing adequate nutritional
support for muscular hypertrophy. Prior to commencement of
the intervention, as well as during 2 separate weeks during the
intervention, weighed diet records were completed on selected
weekday and weekend days. Each participant was provided with
a food scale and instructed how to properly weigh and record
food items. The resultant dietary records were manually analyzed
by reviewing nutrition fact labels and utilizing the USDA Food
Composition Databases (https://ndb.nal.usda.gov/ndb/).
In a double-blind manner, TRF and TRFHMB participants
received placebo (calcium lactate) or calciumHMB supplements,
respectively. HMB and placebo capsules were produced by
the same manufacturer (Metabolic Technologies, Inc.), were
identical in appearance and taste, and were matched for calcium
(102 mg), phosphorus (26 mg), and potassium (49 mg) content.
TRF and TRFHMB participants were instructed to ingest 2
capsules on 3 occasions each day: upon waking, midmorning
while still fasting, and prior to bed, for a total dose of 3
g/d. This dosing strategy (3 g/d, split into 3 doses) has been
utilized in the majority of previous studies examining the effects
of HMB on body composition and physical performance in
active individuals (20). CD participants also received the placebo
capsules for consumption at breakfast, lunch, and dinner using
a unique supplement code to maintain blinding of researchers
with respect to the supplements used in TRF and TRFHMB. All
researchers were blinded to the supplement assignments of the
TRF groups until after data collection and statistical analysis were
completed, at which time the study sponsor provided supplement
codes for unblinding. Additionally, trainers supervising the RT
program were asked not to discuss group assignment with
participants in order to maintain blinding with respect to the
assigned dietary program. Participants were discouraged from
consuming any additional sports supplements beyond those
provided by study investigators, with the exception of common
multivitamin/mineral supplements.
RT program and physical activity monitoring
All groups completed 8 wk of supervised RT in conjunc-
tion with the assigned dietary and supplementation programs.
Training took place within the research laboratories under direct
supervision. RT sessions were completed on 3 nonconsecutive
days each week (i.e., Mondays, Wednesdays, and Fridays),
and 2 different upper- and lower-body sessions were alternated
(Table 1). Participants were instructed to train to momentary
muscular exhaustion during each set, and the load was adjusted
as necessary to ensure compliance with the specified repetition
range. The weights and repetitions completed for each set of
each exercise were recorded to allow calculation of RT volume.
Sessions took place between 1200 and 1800 h. TRF and TRFHMB
participants who performed RT sessions between 1200 and 1300
h were asked to shift their feeding window 1 h earlier (i.e., 1100
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/advance-article-abstract/doi/10.1093/ajcn/nqz126/5527779 by Kennesaw
 State U
niversity user on 19 August 2019
4 Tinsley et al.
4 weeks 4 weeks
Pre-intervention
 
 
 
Baseline Assessments 
 
 
 
 
 
 
 
Midpoint Assessments 
 
 
 
 
 
 
 
Final Assessments 
 
 
 
 
 
 
 
 
 
  = weighed diet record          = accelerometry         = body composition assessment
 
         
   = muscular performance testing         = questionnaires         = indirect calorimetry
= saliva collection          = blood draw          = vascular assessments 
  = assigned eating schedule          = supervised RT program          = supplementation
KEY
FIGURE 1 Study timeline and assessments. RT, resistance training.
to 1900 h) on training days to ensure that RT did not take place
in the fasted state. Following each RT session, participants from
each group were provided with 25 g whey protein (Elite 100%
Whey, Dymatize Enterprises, LLC).
Participants were asked not to perform any RT outside of
the study intervention and to avoid other high-intensity exercise.
In order to objectively assess free-living physical activity levels
during the course of intervention, each participant was provided
with an accelerometer (ActiGraph GT9X Link; Actigraph Inc.)
prior to the commencement of the study intervention, during the
first half of the intervention [i.e., W0 to week 4 (W4)] and during
the second half of the intervention [i.e., W4 to week 8 (W8)].
Participants were instructed to wear the devices during waking
hours, whenever they were not bathing or sleeping, for ≥4 d.
The accelerometer was set to record accelerations at a sampling
rate of 30 Hz, and accelerations were converted into activity
counts per 1-min epoch length during postdata processing. The
activity counts data were screened to determine wear time for
each monitoring day where nonwear time was defined as a
period with ≥60 min of consecutive zero activity counts (i.e.,
no movement), with an allowance ≤2 min of interruption with
activity counts <100 per minute (21). Physical activity energy
expenditure (PAEE; kcal/min) was estimated for each minute
of wear time using the Freedson’s prediction equation (22) for
activity counts>1951 counts/min and theWilliamsWork-Energy
equation for activity counts ≤1951 counts/min (23). Daily PAEE
was averaged across valid days of each participant where a
valid day was defined as a day with ≥10 h of wear time.
Lastly, although the estimated nonwear time was assumed to be
nonwaking hours, average daily PAEE was adjusted by average
wear time for each participant using a least-square adjustment
method (24) due to the possibility of misclassification influencing
daily PAEE.
Overview of laboratory assessments
AtW0,W4, andW8, participants completed 2 testing sessions:
1) a morning assessment conducted after an overnight fast
to assess body composition, resting metabolic rate, substrate
utilization, vascular measures, and subjective factors; and 2) an
afternoon assessment of muscular performance, conducted in the
nonfasted state (Figure 1). For morning assessments, participants
reported to the laboratory after abstention from eating, drinking,
exercising, and utilizing caffeine or nicotine for≥8 h. Participants
were interviewed to confirm adherence to these preassessment
restrictions. The actual abstention from exercise was ≥14 h
due to the scheduling of exercise sessions. Participants reported
to the laboratory wearing athletic clothing, and all metal and
accessories were removed from the body prior to testing. Each
participant voided her bladder and provided a urine sample.
Urine samples were assessed for urine specific gravity using a
digital refractometer (PA201X-093, Misco) to ensure adequate
hydration. Additionally, a standard urinary human chorionic
gonadotropin test was performed to confirm that each participant
was not pregnant. Finally, urine samples were frozen at −80◦C
for assessment of urinary HMB content after study unblinding.
After voiding, each participant’s body mass (BM) and height
were determined via a digital scale with stadiometer (Seca
769). Blood draws were performed at Texas Tech University
Student Health Services after an overnight fast, and participants
completed at-home saliva collections for assessment of the
cortisol awakening response (CAR).
Body composition assessment
Body composition was assessed using a modified 4C model
(25, 26) produced from DXA and bioimpedance spectroscopy
(BIS) data. DXA scans were performed on a Lunar Prodigy
scanner (General Electric) with enCORE software (v. 16.2).
The scanner was calibrated using a quality control block each
morning prior to use, and positioning of participants was
conducted according to the manufacturer’s recommendations.
Each participant was able to fit within the scanning dimensions.
DXAbonemineral content (BMC)was divided by 0.9582 to yield
an estimate of bone mineral (27). Additionally, body volume was
estimated from DXA LST, FM, and BMC using the equation
developed by Wilson et al. (25) for General Electric DXA
scanners:
BV (L) = 0.933∗LST + 1.150∗FM + −0.438∗BMC + 1.504
(1)
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BIS was utilized to obtain total body water estimates. BIS
utilizes Cole modeling (28) and mixture theories (29) to predict
body fluids rather than regression equations used by other
impedance methods [e.g., bioelectrical impedance analysis (30)].
The BIS device used in the present study (SFB7, ImpediMed)
employs 256 measurement frequencies ranging from 4 to 1000
kHz. Each participant remained supine for ≥5 min immediately
prior to assessment using the manufacturer’s recommended
hand-to-foot electrode arrangement. Duplicate assessments were
performed, with the values averaged for analysis. Assessments
were reviewed for quality assurance through visual inspection of
Cole plots.
The 4C equation ofWang et al. (31) was utilized for estimation
of whole-body FM:
FM(kg) = 2.748∗BV − 0.699∗TBW + 1.129∗Mo− 2.051∗BM
(2)
FFM was calculated as BM − FM, and BF% was calculated as
(FM/BM) × 100.
In addition to whole-body composition estimates, MTEF and
MTKE were evaluated via ultrasonography (Logiq e, General
Electric) at W0 and W8. Elbow flexor measurements took place
at 66% of the distance from the acromion of the scapula to
the cubital fossa, and knee extensor measurements took place
at 50% of the distance from the anterior superior iliac spine to
the superior border of the patella (32, 33). These distances were
measured while the participant was standing, and measurement
distances at W0 were recorded for use at W8. All assessments
took place on the right side of the body. In the supine position, the
participant’s arm was abducted to ∼80◦ with the arm supported
for elbow flexor measurements. For knee extensor measurements,
a foam pad was placed beneath the knee to allow ∼10◦ bend
at the knee joint. For all assessments, transmission gel was
generously applied to the marked measurement location, and
minimal pressure was applied by the transducer in order to
avoid tissue compression. Three single transverse images were
taken at each location, with values averaged for analysis. The
gain and depth of the transducer were kept consistent for all
measurements at a given site. Ultrasound images were blinded
for analysis and analyzed by a single blinded researcher using
ImageJ (v. 1.52a; NIH). The reliability of the researcher analyzing
ultrasound images was determined through blinded analysis of
28 randomly selected ultrasound images on 2 occasions. This
exercise producedminimum differences of 0.07 cm forMTEF and
0.14 cm for MTKE.
Muscular performance assessment
Assessments of muscular performance took place between
1200 and 1800 h in the nonfasted state, and participants
were instructed to follow their preferred food and fluid intake
patterns prior to testing. The assessment began with a 5-min
warm-up period using a self-selected pace on a stationary
bicycle. This warm-up period was followed by assessment of
countermovement vertical jump (CMVJ) performance, testing on
a mechanized squat device, and muscular strength and endurance
assessment on the bench press and hip sled exercises. The
CMVJ and hip sled assessments were not performed at the 4-wk
assessment.
For the CMVJ tests, participants completed 8 trials while
wearing their own footwear. Approximately 30 s rest separated
each trial. Ground reaction force (GRF) data were obtained
during the CMVJ using 2 force platforms sampled at 1
kHz (OPT464508; Advanced Mechanical Technology, Inc.).
Participants stood motionless with each foot positioned on a
force platform and their hands on their hips before initiating
the CMVJ with a countermovement action using self-selected
depth and jumping with maximum effort to achieve the highest
vertical displacement possible. No instructions were provided for
the landing phase except to land with each foot contacting its
respective force platform from take-off and to stop downward
motion and return to a motionless standing position. The raw
GRF data from the 2 force platforms were smoothed using a
fourth-order low-pass Butterworth digital filter with a 30 Hz cut-
off frequency. The smoothed GRF from the 2 force platforms
was then summed along the vertical axis to obtain the vertical
GRF acting at the body’s center of mass. The start of the CMVJ
was defined as the time when bodyweight was reduced by 2.5%
(34). Take-off was defined as the time when the summed vertical
GRF decreased below a 20 N threshold (35). Jump time was then
calculated as the time elapsed between the start of the CMVJ and
take-off, expressed in units of seconds. Vertical jump height was
calculated using the impulse-momentum relation and expressed
in units of meters.
Isometric and isokinetic squats were performed using a
mechanized squat device (Exerbotics eSq) (36, 37). At the first
assessment, each participant’s preferred foot positioning was
determined using a custom grid overlaid on the foot platform
of the squat device. This foot positioning was recorded and
utilized for all visits. No weight belts, knee wraps, or other aids
were utilized during testing. Prior to testing, the participant’s
range of motion for isokinetic testing was determined. The range
of motion was set to 90◦ between the thigh and lower leg
at the bottom of the repetition and ∼170◦ at the top of the
repetition, as determined by a goniometer. The isometric testing
included maximal effort pushes at 120◦ and 150◦ knee angles.
Each participant was instructed to push against the device as
hard and fast as possible while attempting to complete a squat
movement. Two isometric pushes were performed at each knee
angle, and each effort lasted∼2 to 3 s. After the isometric testing,
a 3-repetition maximum isokinetic force production test was
completed. Prior to testing, participants observed the movement
of the machine and received verbal instruction regarding proper
performance of the assessment. Each of the repetitions during
the maximal isokinetic force production test consisted of a 4-s
eccentric phase, followed by an approximately half-second pause
at the 90◦ knee position and a 4-s concentric phase. During
testing, the force signal was sampled from the load cell at 1 kHz
(MP100; Biopac Systems, Inc.), stored on a personal computer,
and processed off-line using custom-written software (LabVIEW,
Version 11.0; National Instruments). The scaled force signal was
low-pass filtered, with a 10-Hz cut-off (zero-phase lag, fourth-
order Butterworth filter). All subsequent analyseswere conducted
on the scaled and filtered force signal. For the isometric force
production tests, the rate of force development (RFD) over
specific time intervals (i.e., 30, 50, 100, and 200 ms) was
calculated by manually specifying the onset of force production
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within the custom LabVIEW program. For each repetition of
the maximum isokinetic force production test, isokinetic peak
forces were determined as the highest mean 25-ms epoch for both
concentric and eccentric testing (i.e., PFCON and PFECC).
Resistance exercise performance for the bench press and hip
sled (leg press) exercises was evaluated via the 1-repetition
maximum (1RM) and repetitions to failure (RTF) with 70%
of the W0 1RM. The 1RM testing protocol was based on the
recommendations of the National Strength and Conditioning
Association (38). Briefly, after completing warm-up sets, partic-
ipants completed 2 to 3 repetitions using a load estimated to be
near maximal. 1RM attempts then commenced, with the goal of
obtaining the 1RM in 3 to 5 attempts. Three minutes of rest were
allowed between attempts. Themaximal weight liftedwith proper
form was recorded as 1RM. After the 1RMwas obtained, a 3-min
rest period was allowed before RTF were completed using 70%
of the W0 1RM. For all participants, the bench press was tested
before the hip sled in order to allow recovery of the lower body
following the mechanized squat testing.
Metabolic and physiological measures
REE and substrate utilization were assessed via indirect
calorimetry (TrueOne 2400, ParvoMedics). Gas and flow
calibrations were performed each morning according to the
manufacturer’s specifications, and the preassessment procedures
of Compher et al. (39) were utilized. Participants were instructed
to remain motionless but awake during the assessment, which
took place in a climate-controlled room with the lights dimmed.
The first 5 min of each test were discarded, and the assessment
continued until there was a period of 5 consecutive minutes with
a CV for REE of ≤5%. The average CV for REE in the present
study was 3.2% ± 1.1% (mean ± SD).
Brachial blood pressure was measured using an automated
cuff-based sphygmomanometer (HEM-907, Omron Healthcare).
From this measurement, mean blood pressure and diastolic blood
pressure were used to calibrate ensemble-averaged pressure
waveforms measured at the left radial artery using applanation
tonometry (SphygmoCor PVx, AtCor Medical). A general
transfer function was also used to synthesize a central aortic
waveform from the radial artery measurement. Wave separation
analysis of the aortic pressure waveform allowed estimation
of aortic pulse wave velocity, an index of arterial stiffness.
Each participant remained supine for ≥10 min prior to vascular
assessment. Duplicatemeasurements were obtained and averaged
for analysis.
Blood samples, collected by certified health professionals,
were transported via courier to a local clinical laboratory for
analysis (University Medical Center Health System). Testing
was performed using standard instrumentation (Cobas 6000,
Roche Diagnostics) and following procedures outlined by
the manufacturer. Total cholesterol, triglycerides, and HDL
cholesterol were assessed using enzymatic colorimetric assays
(40–42), and VLDL and non-HDL cholesterol were calculated
(VLDL = triglycerides/5 (43); non-HDL = total cholesterol –
HDL). LDL cholesterol was calculated using theMartin–Hopkins
equation (44). Glucose was measured using an enzymatic UV test
(45), and insulin was assessed via an electrochemiluminescence
immunoassay (46). Results of the clinical laboratory analyses
were provided to study investigators.
Each participant was familiarized with the saliva collection
procedures at study commencement. Saliva collection took
place using the passive drool method, with allows saliva to
be transferred from the mouth to a small vial according to
the manufacturer’s recommendations (47). Three saliva samples
were collected during both the preintervention period and the
final week of the intervention for assessment of CAR [the
characteristic increase in cortisol concentrations upon waking
(48)]. These samples were collected at the participant’s home
0, 30, and 45 min after waking. The importance of collecting
the saliva sample exactly as instructed was strongly emphasized
to research participants. Each participant was provided with
a reminder sign to place by the bedside and instructed to
set an alarm for saliva collection timepoints. Upon obtaining
the sample, each participant was instructed to place the vial
in the freezer until it could be transported to the laboratory.
Upon delivery to the lab, each vial of saliva was stored at
−80◦C until shipment to a saliva testing facility for analysis
(Salimetrics LLC). For the analysis, samples were thawed to
room temperature, vortexed, and then centrifuged for 15 min at
∼1500 × g immediately before performing the assay. Samples
were tested for salivary cortisol using a high-sensitivity enzyme
immunoassay (Cat. No. 1–3002). The sample test volume was
25 μL of saliva per determination. The assay has a lower limit
of sensitivity of 0.007 μg/dL, a standard curve range from
0.012–3.0 μg/dL, an average intra-assay CV of 4.60%, and an
average interassay CV of 6.00%, which meets the manufacturer’s
criteria for accuracy and repeatability in Salivary Bioscience,
and exceeds the applicable NIH guidelines for Enhancing
Reproducibility through Rigor and Transparency.
Questionnaires
As part of the screening procedures, participants were inter-
viewed using a lifestyle questionnaire to determine typical eating
and exercise habits. Participants completed follow-up lifestyle
questionnaires at subsequent research visits. Additionally, par-
ticipants completed the Mood and Feelings Questionnaire (49),
the Pittsburgh Sleep Quality Index (50), the Three-Factor Eating
Questionnaire Revised 18-item version (51), and a menstrual
cycle questionnaire at each morning laboratory assessment
session.
Statistical analysis
An a priori power analysis was performed (G∗Power, v.
3.1.9.2) using an effect size (ES) estimated from a previous
investigation of TRF and RT (8). FMwas specified as the primary
dependent variable for the power analysis, and the ES used for
the power analysis was the observed ES for FM reduction in TRF
minus the ES for FM reduction in the control group. Using this ES
(d = 0.46), a α error probability of 0.05, and power of 0.8, it was
estimated that 15 participants were needed to detect significant
changes in FM.When the power analysis was performed using an
ES for muscular performance improvement from the same study
(d= 0.25), the software estimated that 36 participants are needed
to detect significant changes. Therefore, in order to promote
adequate power for less sensitive measures and accounting for
a 10% attrition rate, the target sample size was 40.
All data analysis occurred prior to the unblinding of study
investigators and prior to receipt of urinary HMB concentrations.
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Data were analyzed in the intention-to-treat (ITT) framework
using a model-based likelihood method, meaning that the
intervention effects were estimated from all participants who
were randomly assigned into the groups regardless of whether
they complied with the intervention protocol (e.g., missing at
follow-up assessments or drop-outs). Additional per protocol
(PP) analyses were performed by excluding participants who
dropped out of the study or failed to comply with the study
protocol (defined as <80% compliance with the assigned eating
schedule, completing fewer than 22/24 RT sessions, or <70%
compliance with capsule supplements as determined by capsule
counts). For both ITT and PP analyses, a linear mixed model with
restricted maximum likelihood method was used to test changes
in outcome variables over time across groups (i.e., CD, TRF,
and TRFHMB). The model was established based on unstructured
variance-covariance structure for the repeated measure and
missing values were assumed to be missing at random. The
normality of residuals assumption was tested using visual
examination of Q-Q plots. If the group by time interaction effect
was significant, simple effects tests were performed using one-
factor or repeated measures ANOVA as appropriate, followed
by Sidak’s pairwise comparisons using a Bonferroni adjusted
α level for each test. In the absence of statistically significant
group by time interactions, main effects were examined with
follow-up using Sidak’s pairwise comparisons. Cohen’s d ES
were calculated for each group by dividing the difference between
W0 and W8 values by the pooled SD. A familywise α level
of <0.05 was used for statistical significance, and all data
analyses were performed using IBM SPSS v. 25 and Microsoft
Excel v. 16.16.3. Data in the text, tables, and figures of this
article represent results of the ITT analysis unless otherwise
specified. Results from the PP analysis, as well as supplemental
data for both analyses, are included in the online supporting
material.
Results
Participants
Forty participants were randomly assigned and included in the
ITT analysis, and 24 participants were included in the PP analysis
(Figure 2). No baseline differences were present between
groups (Table 2; Supplemental Table 1). Although participants
were not excluded for noncompliance in the ITT analysis,
average group compliance with the assigned protocol was ≥89%
for the assigned eating schedule and ≥84% for the assigned
capsule supplementation based on capsule count (Supplemental
Table 2). Urinary HMB concentrations increased significantly in
TRFHMB from the preintervention period to the intervention, with
no changes in CD or TRF (Supplemental Table 3).
Nutrition and supplementation
Prior to the intervention, there were no differences in the
time of the first or last eating occasion of the day, nor the
total duration of the feeding window (Supplemental Table 4).
During the intervention, the time of the first eating occasion
was later in TRF and TRFHMB compared with CD, whereas
the time of the last eating occasion was later in CD. These
differences resulted in a significantly longer feeding window for
CD (13.2 ± 1.6 h/d) compared with TRF (7.5 ± 0.6 h/d) and
TRFHMB (7.6 ± 0.7 h/d). Within the feeding windows, the meal
frequency did not differ between groups before or during the
intervention.
Analysis of weighed diet records prior to intervention com-
mencement indicated that all groups reported an average energy
intake that was comparable to W0 REE. During the intervention,
reported energy intake increased in all groups (mean change
from 23 to 194 kcal/d depending upon the group), with no
differences between groups (Table 3; Supplemental Table 5).
The magnitude of increase in energy intake approximated the
average daily calories consumed from the provided whey protein
supplements (∼200–250 kcal/d for all participants). Despite this
increase in energy intake, reported caloric consumption remained
only slightly greater than W0 and W8 REE and was below the
original energy intake goal of REE × 1.5 – 250 kcal/d. Protein
consumption in all groups increased from habitual intakes of 1.1
to 1.2 g/kg/d, as estimated during the preintervention period, to
an intake of 1.6 g/kg/d in all groups during the intervention.
Carbohydrate and fat intake generally did not change during the
intervention.
RT program and physical activity monitoring
There were no differences between groups for upper- or lower-
body session volume or total RT volume (Supplemental Table
6). In all groups, volume increased from the first half of the
intervention (i.e.,W0 toW4) to the second half of the intervention
(i.e., W4 to W8), with the magnitude of increase in group session
volume ranging from 17% to 27%. During the intervention, group
step counts ranged from 7166 to 9179 steps/d, with no significant
differences between groups or across time (Supplemental Table
7). Group by time interactions were present for PAEE, sedentary
time, and light intensity PA. Follow-up analysis indicated that
differences between groups were present in the preintervention
period for sedentary time and light intensity PA, but not during
the first or second half of the intervention. Furthermore, no
statistically significant differences between time points within a
group were observed, with the exception of higher sedentary time
observed in the TRF group during the first half of the intervention
compared with preintervention.
Body composition
FFM, MTEF, and MTKE increased in all groups without
differences between groups (Supplemental Table 8). In the
ITT analysis, time main effects indicated decreases in FM and
BF% for all groups combined (Figure 3). In the PP analysis,
significant group by time interactions indicated reductions in
FM for TRF and TRFHMB relative to CD at specific time points
(Supplemental Figure 1). Although FM was significantly lower
atW4 thanW0 in TRF, FM atW8 did not significantly differ from
W0. In contrast, FM and BF% in TRFHMB were lower at W8 than
W0 in the PP analysis (Supplemental Table 8).
Muscular performance
Maximal strength and muscular endurance improved in
all groups without statistically significant differences between
groups (Figure 4; Supplemental Figure 2; Supplemental Table
9). In both the ITT and PP analyses, several RFD variables
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Assessed for eligibility
(n = 70)
Excluded (n = 30)
- Not meeting inclusion criteria (n = 25) 
- Declined to participate (n = 5) 
Randomly assigned (n = 40) 
- Stratified by BF%
and breakfast
consumption 
Allocated to CD (n = 14)
- Received allocated intervention (n = 14)
Ceased participation before mid-point
(n = 1)
- Dropped (failure to attend) (n = 1) 
Ceased participation after mid-point (n = 4)
-Dropped from study (failure to attend)
(n = 2)
-Discontinued intervention (scheduling
conflicts, disinterest) (n = 2)
Allocated to TRF (n = 13)
- Received allocated intervention (n = 13)
Ceased participation before mid-point
(n = 1)
- Discontinued intervention (scheduling
conflict) (n = 1)
Ceased participation after mid-point
(n = 0)
Allocated to TRFHMB (n = 13)
- Received allocated intervention (n = 13)
Ceased participation before mid-point
(n = 1)
- Discontinued intervention (dislike of TRF
program) (n = 1) 
Ceased participation after mid-point (n = 2)
-Dropped from study (failure to attend)
(n = 1)
-Discontinued intervention (scheduling
conflict) (n = 1)
Included in ITT analysis (n = 14)
Completed entire study (n = 9)
- Included in PP analysis (n = 9) 
 
Included in ITT analysis (n = 13)
Completed entire study (n = 12)
- Included in PP analysis (n = 8)
- Excluded due to supplementation 
 noncompliance (n = 2)
- Excluded for dietary noncompliance
(n = 2) 
Included in ITT analysis (n = 13)
Completed entire study (n = 10)
- Included in PP analysis (n = 7)
- Excluded due to supplementation 
 noncompliance (n = 3)
FIGURE 2 CONSORT flow chart. BF%, body fat percentage; CD, control diet; ITT, intention-to-treat; PP, per protocol; TRF, time-restricted feeding;
TRFHMB, time-restricted feeding plus β-hydroxy β-methylbutyrate supplementation.
were improved in all groups, with more consistent improvements
observed in the ITT analysis (Supplemental Table 10). A trend
(P = 0.06) for a time main effect for increased jump height
was also observed in the ITT analysis, although the ES in CD
(d = 0.63) and TRFHMB (d = 0.65) appeared larger than TRF
(d = 0.00), and no significant effects were present in the PP
analysis (Supplemental Table 11).
Metabolic and physiological variables
No significant changes in REE or RQ were observed in any
group (Supplemental Table 12). Blood markers were generally
unchanged by the study intervention (Supplemental Table 13).
No significant changes in vascular assessments, CAR, or average
cortisol concentrations were observed (Supplemental Tables 14
and 15).
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TABLE 2 Participant characteristics1
CD (n = 14) TRF (n = 13) TRFHMB (n = 13) P (group)
Age, y 22.0 ± 2.4 22.1 ± 2.1 22.3 ± 3.4 0.95
Body mass, kg 64.6 ± 8.8 63.8 ± 8.5 63.2 ± 6.1 0.89
Height, cm 169.4 ± 7.5 163.6 ± 5.9 166.0 ± 4.8 0.07
RT experience, y 5.4 ± 3.0 5.0 ± 1.9 5.1 ± 2.1 0.85
Current RT, d/wk 2.9 ± 0.5 3.3 ± 0.6 3.0 ± 0.9 0.22
1Data are presented as mean ± SE. P values are from one-factor ANOVA. Data from intention-to-treat analysis are displayed, and data from per protocol
analysis are displayed in the online supporting material. CD, control diet; RT, resistance training; TRF, time-restricted feeding; TRFHMB, time-restricted
feeding plus β-hydroxy β-methylbutyrate supplementation.
Questionnaires
Overall, no major side effects or adverse events occurred
during the study. At W4, 84% of participants reported no side
effects. Reported side effects included both suppressed appetite
(n= 1) and increased appetite with associated irritability (n= 1)
in TRF, morning fatigue in TRFHMB (n = 1), nausea in CD
(n = 1), and bloated stomach in CD and TRFHMB (n = 1 each).
At W8, 90% of participants reported no side effects. Reported
TABLE 3 Nutrient intake1
Group2 Preintervention3
During
intervention   (%) P (group) P (time) P (I)
Energy,
kcal
CD 1384 ± 117 1570 ± 111 186 13 0.91 0.01 0.62
TRF 1430 ± 121 1624 ± 107 194 14
TRFHMB 1466 ± 111 1489 ± 112 23 2
Protein
g CD 67 ± 7 98 ± 7 31 46 0.49 <0.0001 0.87
TRF 79 ± 8 105 ± 6 26 33
TRFHMB 77 ± 8 102 ± 7 25 32
% CD 20 ± 2 27 ± 2 7 35 0.67 <0.0001 0.48
TRF 23 ± 2 27 ± 2 4 17
TRFHMB 21 ± 2 28 ± 2 7 33
g/kg CD 1.1 ± 0.1 1.6 ± 0.1 0.5 45 0.58 <0.0001 0.82
TRF 1.2 ± 0.1 1.6 ± 0.1 0.4 33
TRFHMB 1.2 ± 0.1 1.6 ± 0.1 0.4 33
Carbohydrate
g CD 158 ± 15 165 ± 17 7 4 0.58 0.90 0.83
TRF 167 ± 16 157 ± 16 −10 −6
TRFHMB 146 ± 16 145 ± 17 −1 −1
% CD 47 ± 3 42 ± 2 −5 −11 0.24 0.045 0.58
TRF 45 ± 3 39 ± 2 −6 −13
TRFHMB 40 ± 3 39 ± 2 −1 −3
g/kg CD 2.5 ± 0.3 2.6 ± 0.3 0.1 4 0.59 0.82 0.81
TRF 2.7 ± 0.3 2.5 ± 0.3 −0.2 −7
TRFHMB 2.3 ± 0.3 2.3 ± 0.3 0.0 0
Fat
g CD 51 ± 10 54 ± 6 3 6 0.46 0.74 0.12
TRF 52 ± 11 64 ± 5 12 23
TRFHMB 75 ± 11 53 ± 6 −22 −29
% CD 34 ± 3 32 ± 2 −2 −6 0.34 0.24 0.20
TRF 32 ± 3 34 ± 2 2 6
TRFHMB 39 ± 3 32 ± 3 −7 −18
g/kg CD 0.8 ± 0.2 0.9 ± 0.1 0.1 13 0.46 0.80 0.11
TRF 0.8 ± 0.2 1.0 ± 0.1 0.2 25
TRFHMB 1.2 ± 0.2 0.8 ± 0.1 −0.4 −33
1Data are presented as mean ± SE. P values are from mixed model analysis. Data from intention-to-treat analysis are displayed, and data from per
protocol analysis are displayed in the online supporting material. CD, control diet; I, group by time interaction; TRF, time-restricted feeding; TRFHMB,
time-restricted feeding plus β-hydroxy β-methylbutyrate supplementation.
2n = 40 (CD: n = 14; TRF: n = 13; TRFHMB: n = 13).
3No preintervention differences between groups were present.
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FIGURE 3 Body composition changes. Results from intention-to-treat
analysis are displayed [n = 40 (CD: n = 14; TRF: n = 13; TRFHMB:
n = 13)], and data from per protocol analysis are displayed in the online
supporting material. Percent changes (mean ± SE) displayed as differences
between W0 and W8 values relative to W0 values for each variable. Total
body composition was estimated using a 4-component model, and muscle
thickness was assessed via ultrasonography. Asterisks with brackets indicate
significant changes in all groups (i.e., time main effects), with nonsignificant
differences between groups, based on mixed model analysis and follow-
up tests. BF%, body fat percentage; BM, body mass; CD, control diet;
FM, fat mass; FFM, fat-free mass; MTEF, ultrasound muscle thickness of
elbow flexors; MTKE, ultrasound muscle thickness of knee extensors; TRF,
time-restricted feeding; TRFHMB, time-restricted feeding plus β-hydroxy β-
methylbutyrate supplementation.
side effects included suppressed appetite (n = 1) in TRF and
bloated stomach in both TRF and TRFHMB (n = 1 each). With
one exception, the side effects reported at W8 were the same as
reported at W4 (i.e., the same participants and same specific side
effects).
No differences between groups were observed for question-
naire responses. A time main effect indicated improvement in
scores for the Mood and Feelings Questionnaire at W4 and
W8 compared with W0 in all groups (Supplemental Table
16). The uncontrolled eating score of the Three Factor Eating
Questionnaire was reduced across time in all groups. The
proportion of participants with regularly occurring menstrual
cycles in each group ranged from 69 to 79% (Supplemental
Table 17).
Discussion
To our knowledge, the present investigation is the first
controlled trial of IF plus RT in female participants. The purpose
of the trial was to compare the effects of TRF, with or without
HMB supplementation during fasting periods, to a CD requiring
breakfast consumption during progressive RT. The primary
finding was that following a TRF program in which all calories
were consumed within ∼7.5 h/d did not impair gains in FFM,
skeletal muscle hypertrophy, or muscular performance compared
with a CD with feeding spread over ∼13 h/d when all diets were
similar in energy and protein intake.
An increasing amount of research has reported the physiolog-
ical effects of IF in general (1, 3–5, 52) and TRF in particular
(53–56), although a very limited number of controlled trials have
taken place in active individuals (6–8). Bhutani et al. (6) found
that 12 wk of ADF plus endurance exercise produced greater
improvements in body composition and blood lipids than ADF
or exercise alone in lightly active obese adults. Tinsley et al. (7)
employed an 8-wk TRF programwith a 4-h feeding period for 4 d
perweek and ad libitum feeding plus RT for 3 d perweek in young
recreationally active males. Although not statistically significant,
there was an apparent attenuation in LST gains with TRF (−0.2
kg; d = −0.02) compared with the unrestricted CD (+2.3 kg;
d = 0.25). However, protein intake in the TRF group was not
only lower than the CD (1.0 compared with 1.4 g/kg/d), but also
suboptimal for active individuals (9, 10). Despite discrepancies in
protein intake and LST accretion, comparable improvements in
muscular strength and endurance were observed in both groups.
Finally,Moro et al. (8) examined 8wk of TRFwith an 8-h feeding
period each day in conjunction with RT in resistance-trained
males. Both TRF and control groups employed an identical meal
frequency and were counseled to maintain habitual energy and
macronutrient intake throughout the intervention, including 1.9
g/kg/d of protein. Although both groups maintained FFM and
experienced similar changes in muscular performance, the TRF
program produced significant reductions in FM and differential
responses in inflammatory markers and circulating hormone
concentrations. Although these and other data have demonstrated
effects of IF on a variety of physiological markers (1, 3–5, 52,
53), these variables were generally unchanged in the present trial.
This finding may be partially attributable to the healthy, active
population and lack of energy restriction relative to habitual
intake.
In the present investigation, adherence to TRF did not attenuate
FFM accretion, skeletal muscle hypertrophy, or improvements
in muscular performance. Differential effects on FM (CD: +2%
relative to baseline; TRF: −2% to −4%; TRFHMB: −4% to
−7%) were only observed in the PP analysis, with significant
reductions in FM and BF% in TRFHMB at W8. It has been
recognized that longitudinal data are needed to elucidate the
impact of the daily distribution of protein intake on adaptations to
RT (9). As IF necessitates prolonged periods without stimulation
of muscle protein synthesis and suppression of muscle protein
breakdown via dietary amino acids (13), it represents an
opportunity to investigate this question. The present results
reveal no detrimental effects on RT adaptations of limiting all
protein and other nutrient intake to ∼7.5 h/d compared with
∼13 h/d. In the context of IF, it has also been questioned
whether implementation of modified fasting periods to allow
ingestion of selected amino acids or their metabolites may be
beneficial for lean mass maintenance or accretion, particularly in
active individuals (14). The branched-chain amino acid leucine
is known to stimulate protein synthesis through the mechanistic
target of rapamycin (mTOR) signaling pathway and produces
metabolites that may modulate its physiological effects (14, 57,
58). Due to its ability to stimulate muscle protein synthesis
and attenuate muscle proteolysis (15), it has been hypothesized
that the leucine metabolite HMB may exert favorable effects on
body composition and performance in exercising and/or energy-
restricted individuals (16–18). However, previous investigations
of supplemental HMB in active populations have produced
mixed results, and a recent meta-analysis in athletes revealed
no definitive advantages for body composition or muscular
performance (20). The present investigation may be the first
trial to directly examine the influence of supplementation with a
leucine metabolite during IF and does not reveal distinct benefits
of HMB supplementation.
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FIGURE 4 Muscular performance changes. Results from intention-to-treat analysis are displayed [n= 40 (CD: n= 14; TRF: n= 13; TRFHMB: n = 13)],
and data from per protocol analysis are displayed in the online supporting material. Percent changes (mean+ SE) displayed as differences betweenW0 andW8
values relative to W0 values for each variable. Asterisks with brackets indicate significant changes in all groups (i.e., time main effects), with nonsignificant
differences between groups, based on mixed model analysis and follow-up tests. Muscular strength and endurance were evaluated on the hip sled (leg press)
and bench press exercises, peak forces were obtained from isokinetic squat testing, rate of force development was obtained from isometric squat testing,
and jump height was calculated using force platforms. 120◦, 120◦ knee angle for isometric squat testing; 150◦, 150◦ knee angle for isometric squat testing;
1RMBP, 1-repetition maximum on bench press; 1RMLP, 1-repetition maximum on leg press; CD, control diet; JH, jump height; PFCON, peak concentric force
on mechanized squat; PFECC, peak eccentric force on mechanized squat; RFD, rate of force development (durations over which RFD values were calculated
are shown in subscripts); RTFBP, repetitions to failure on bench press; RTFLP, repetitions to failure on leg press; TRF, time-restricted feeding; TRFHMB,
time-restricted feeding plus β-hydroxy β-methylbutyrate supplementation.
It is worth emphasizing that the dietary advice provided in the
present investigation was minimal. Specifically, each participant
met briefly (<10 min) to discuss the assigned eating schedule
and protein consumption target with the primary investigator
at the time of group assignment. Two additional follow-up
visits of similar duration allowed discussion of the results of
weighed diet records. As estimated energy intake was typically
below the target intake, the primary dietary feedback was
to achieve a high protein intake through consumption of the
provided whey protein supplement and protein-containing foods.
In all groups, average protein intake increased from 1.1 to 1.2
g/kg/d in the preintervention period to 1.6 g/kg/d during the
study intervention, a range consistent with optimal intake for
muscular adaptations (9, 10). Although weighed diet records
revealed no significant differences between groups for energy or
macronutrient intake, the shortcomings of self-reported dietary
intake arewell-established, and resultant nutrient intake estimates
should be viewed with substantial caution (59, 60). Due to the
relative likelihood of behavioral modification or underreporting
on diet tracking days, it is possible that both the energy
and macronutrient content of the diet actually consumed by
participants in all groups was higher than the estimates obtained
from weighed diet records.
Strengths of the present study include rigorous body com-
position assessment methodology, including preassessment and
procedural standardization and implementation of a 4C model
compared with previous investigations utilizing DXA (7, 8).
Additional strengths were the fully supervised RT program,
double blinding of data collection and analysis with respect
to HMB and placebo supplements, and the wide range of
performance and physiological variables examined. Limitations
include reliance on a limited number of weighed dietary records,
an inability to objectively confirm adherence to TRF, inclusion of
female participants only, and a lack of mechanistic examinations
of adaptations to TRF and HMB supplementation.
In summary, similar gains in FFM, skeletal muscle hy-
pertrophy, and muscular performance can be achieved with
dramatically different feeding schedules provided that energy
and protein intake are similar during a progressive RT program.
In a healthy, active female population, TRF did not produce
changes in physiological variables including resting metabolic
rate, substrate utilization, blood lipids, glucose and insulin, blood
pressure, arterial stiffness, or cortisol responses. Although a
possible benefit of HMB for fat loss was observed in the PP
analysis, supplementation did not definitively improve outcomes
during TRF. Due to their potential to favorably influence
body composition without compromising physical performance,
additional examination of various IF protocols in both sedentary
and active populations is warranted.
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